Nantahala Capital Management, LLC Adicet Bio, Inc. Transaction History

Nantahala Capital Management, LLC

  • $2.22 Billion
  • Q1 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$7.37 - $17.49 $2.29 Million - $5.43 Million
-310,540 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$9.19 - $15.93 $784,228 - $1.36 Million
-85,335 Reduced 21.56%
310,540 $3.2 Million
Q1 2021

May 14, 2021
BUY
$12.12 - $17.17 $628,591 - $890,504
51,864 Added 15.08%
395,875 $5.18 Million
Q4 2020

Feb 16, 2021
SELL
$10.36 - $14.77 $737,404 - $1.05 Million
-71,178 Reduced 17.14%
344,011 $4.83 Million
Q3 2020

Nov 16, 2020
BUY
$10.18 - $21.4 $4.23 Million - $8.89 Million
415,189 New
415,189 $4.94 Million

Others Institutions Holding ACET

# of Institutions
63
Shares Held
57.4M
Call Options Held
36.9K
Put Options Held
16.5K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $30M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email